Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017

Jul. 31, 2017 SAN DIEGO, July 31, 2017 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest advancements in clinical and research-based solutions during the 2017 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, being held July 31 – August 3 at the San Diego Convention Center. Among the products displayed within booth #4039 is a... Read more

New England Biolabs® and TTP plc collaborate to provide services for molecular diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products CAMBRIDGE, England and IPSWICH, Mass., July 28, 2017 /PRNewswire/ — TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce... Read more

Unique concept of MDx, Seegene Random Access System, announced at AACC 2017

Seoul, South Korea – July 26, 2017 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the “System”) at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July 30 to August 3. The ‘Seegene Random Access... Read more

Agilent Technologies Introduces Real-Time PCR System for Clinical Diagnostics in Europe

AriaDx Provides Modular Solution for Diagnostic Labs and Assay Developers SANTA CLARA, Calif., July 25, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic... Read more

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif., July 24, 2017 Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies... Read more

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 24, 2017– Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population... Read more

Agilent Acquires Powerful Next Generation Sequencing IP Portfolio

Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 24, 2017– Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population... Read more

Thermo Fisher Scientific Announces Asia Precision Medicine Research Array for Regional Screening Initiatives

New genotyping tool reduces cost and complexity of analysis associated with whole genome sequencing to more efficiently advance clinical research of diseases in Asians SANTA CLARA, Calif., July 19, 2017 /PRNewswire/ — Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation among East and South Asian populations now have access to... Read more

Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research

Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven Fluidigm® microfluidic technology.... Read more

Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform

SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications based on the PacBio® Sequel® System. New applications developed under this agreement... Read more